AWM
BIIB icon

Altavista Wealth Management’s Biogen BIIB Stock Holding History

Altavista Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-760
Closed -$238K – 144
2017
Q3 		$238K Buy
+760
New +$225K 0.11% 127
2017
Q2 		– Sell
-1,017
Closed -$278K – 127
2017
Q1 		$278K Sell
1,017
-241
-19% -$68.1K 0.14% 111
2016
Q4 		$357K Sell
1,258
-297
-19% -$88K 0.19% 88
2016
Q3 		$487K Sell
1,555
-371
-19% -$110K 0.27% 77
2016
Q2 		$466K Buy
1,926
+131
+7% +$34.5K 0.26% 77
2016
Q1 		$467K Buy
1,795
+235
+15% +$62.1K 0.26% 80
2015
Q4 		$478K Buy
1,560
+55
+4% +$15.8K 0.28% 78
2015
Q3 		$439K Buy
1,505
+12
+0.8% +$3.96K 0.29% 82
2015
Q2 		$603K Sell
1,493
-7
-0.5% -$2.81K 0.37% 63
2015
Q1 		$633K Sell
1,500
-50
-3% -$19.7K 0.39% 60
2014
Q4 		$530K Buy
1,550
+206
+15% +$66.6K 0.33% 66
2014
Q3 		$445K Sell
1,344
-340
-20% -$112K 0.29% 70
2014
Q2 		$531K Sell
1,684
-834
-33% -$251K 0.33% 70
2014
Q1 		$770K Buy
2,518
+784
+45% +$249K 0.47% 63
2013
Q4 		$485K Sell
1,734
-465
-21% -$120K 0.3% 79
2013
Q3 		$529K Sell
2,199
-50
-2% -$11.2K 0.34% 72
2013
Q2 		$484K Buy
+2,249
New +$481K 0.33% 72

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Altavista Wealth Management's BIIB Position: Q4 2017 in Review

Altavista Wealth Management sold out of Biogen (BIIB) in Q4 2017, closing a stake of 760 shares — an estimated $238K sold.

Altavista Wealth Management first reported a position in BIIB in Q2 2013 and held it in 17 quarters. The position peaked at $770K in Q1 2014. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Altavista Wealth Management reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Altavista Wealth Management sold 760 Biogen shares in Q4 2017, an estimated $238K.
  • Altavista Wealth Management first reported a position in Biogen in Q2 2013 and held it in 17 quarters.
  • Altavista Wealth Management's Biogen position peaked at $770K in Q1 2014.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Altavista Wealth Management's 13F filing for Q4 2017, filed 13 Feb 2018.